BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19810145)

  • 1. Lipid profile as a prognostic factor in cancer patients.
    Cvetkovic Z; Cvetkovic B; Petrovic M; Ranic M; Debeljak-Martarcic J; Vucic V; Glibetic M
    J BUON; 2009; 14(3):501-6. PubMed ID: 19810145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
    Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD
    Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of alterations in plasma lipid profile levels in breast cancer.
    Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel
    Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of serum lipase [EC 3.1.1.3] and the diversity of serum lipid profile in psoriasis.
    Pietrzak A; Lecewicz-Toruń B
    Med Sci Monit; 2002 Jan; 8(1):CR9-CR13. PubMed ID: 11782673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of lipids (cholesterol, triglycerides and phospholipids), plasma lipoproteins (HDL-cholesterol) and apoproteins (apo A and apo B in patients with acute myocardial infarction].
    Paniagua J; Martínez Muñoz A; Tuset N; Gras J
    Med Clin (Barc); 1989 Jun; 93(4):134-8. PubMed ID: 2796436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid profile in pubescent athletes.
    Taralov Z; Boyadjiev N; Georgieva K
    Acta Physiol Pharmacol Bulg; 2000; 25(1):3-8. PubMed ID: 11140190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy].
    Morimoto K; Koh M
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1517-24. PubMed ID: 15508443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
    Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
    Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
    Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
    Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma.
    Cvetković Z; Vucić V; Cvetković B; Petrović M; Ristić-Medić D; Tepsić J; Glibetić M
    Ann Hematol; 2010 Aug; 89(8):775-82. PubMed ID: 20127484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of cholesterol and other lipids from a lipid nanoemulsion to high-density lipoprotein in heart transplant patients.
    Puk CG; Bocchi EA; Lo Prete AC; Ferreira SM; Stolf NA; Maranhão RC
    J Heart Lung Transplant; 2009 Oct; 28(10):1075-80. PubMed ID: 19782290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY
    Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
    Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids in ischemic stroke subtypes.
    Laloux P; Galanti L; Jamart J
    Acta Neurol Belg; 2004 Mar; 104(1):13-9. PubMed ID: 15143957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.